A Versatile Multi-Modal Agent for Rare Disease Diagnosis and Risk Gene Prioritization

Published: 29 May 2026, Last Modified: 29 May 2026ACL 2026 Workshop CustomNLP PosterEveryoneRevisionsCC BY 4.0
Keywords: AI Agent, rare disease diagnosis
TL;DR: An AI agent for rare disease diagnosis
Abstract: Accurate and timely diagnosis is essential for effective treatment, particularly in the context of rare diseases. However, current diagnostic workflows often lead to prolonged assessment times and low accuracy. To address these limitations, we introduce Hygieia, an adaptive AI agent system designed to support precision disease diagnosis by integrating diverse data sources, including phenotypic features, genetic profiles, and clinical records. Hygieia features a router-based and knowledge-enhanced framework that mitigates hallucination and tailors diagnostic strategies to different disease categories. Notably, it prioritizes risk-related genomic factors for rare diseases and provides confidence scores to assist clinical decision-making. We conducted a comprehensive evaluation demonstrating that Hygieia achieves state-of-the-art performance across multiple diagnostic benchmarks. In collaboration with clinical experts from Yale School of Medicine and Duke-NUS Medical School, we further validated its practical utility by showing (1) Hygieia’s superior diagnostic performance compared to physicians and (2) its effectiveness in assisting clinicians with medical records for handling real-world cases. Our findings indicate that Hygieia not only enhances diagnostic accuracy and interpretability but also significantly reduces clinician workload, highlighting its potential as a valuable tool in clinical decision support systems.
Email Sharing: We authorize the sharing of all author emails with Program Chairs.
Data Release: We authorize the release of our submission and author names to the public in the event of acceptance.
Submission Number: 12
Loading